Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Surrey M. Walton

Surrey M. Walton


Professor, College of Pharmacy-Pharmacy Systems Outcomes and Policy
Assistant Director, Center for Pharmaco Epidemiology and Pharmacoeconomic Research
Core Faculty Member, Center for Pharmacoeconomic Research

Contact

Address:

833 S Wood St. (M/C 871) Rm 264, Chicago, IL

Related Sites:

About Heading link

Overview:
Surrey Walton is a Professor in the Department of Pharmacy Systems Outcomes and Policy and Assistant Director in the Center for Pharmacoepidemiology and Pharmacoeconomic Research. Prior to arriving at UIC, Dr. Walton received his Ph.D. in Economics from the University of Chicago in 1997, where he specialized in labor and health economics.

Research Interests:
Areas of interest include economic evaluation of health care services and policy, decision analytic modeling, cost and outcomes assessments, and studies of the pharmacy workforce.

Teaching Statement:
Coordinate and teach Pharm D and graduate level courses in the economic evaluation of health care services and have served on numerous graduate thesis committees for PSOP, and the school of public health.

Teaching and Supervision Heading link

Ph.D. Thesis Research (PSOP 599), 1/10/2022 – 4/29/2022
Pharmacoeconomics and Payment (PHAR 565), 8/23/2021 – 12/3/2021
Pharmacoeconomics and Payment (PHAR 565), 8/23/2021 – 12/3/2021
Ph.D. Thesis Research (PSOP 599), 8/23/2021 – 12/3/2021
Econmc Eval of Hlthcr Interven (PSOP 573), 8/23/2021 – 12/3/2021
Independent Study (PSOP 596), 6/14/2021 – 8/6/2021
Ph.D. Thesis Research (PSOP 599), 1/11/2021 – 4/30/2021
Pharmacoeconomics and Payment (PHAR 565), 8/24/2020 – 12/4/2020
Pharmacoeconomics and Payment (PHAR 565), 8/24/2020 – 12/4/2020

Selected Grants

2022 - 2023 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2022 - 12/31/2023, Obligated Amount: $340000; Anticipated Amount: $340000

Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders, Oregon Research Behavioral Intervention Strategies., 9/18/2021 - 5/31/2022, Obligated Amount: $222082; Anticipated Amount: $222082

AbbVie Fellowship 2021-2023 - Surrey Walton and Monika Mandava, AbbVie, Inc.., 5/17/2021 - 5/16/2023, Obligated Amount: $199383; Anticipated Amount: $199383

Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women, National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development)., 9/4/2020 - 8/31/2023, Obligated Amount: $1693972; Anticipated Amount: $2565146

2020 - 2021 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2020 - 12/31/2021, Obligated Amount: $425000; Anticipated Amount: $425000

Engaging men from blue-collar industries in weight loss: Tailoring recruitment and treatment approaches, National Institutes of Health., 7/1/2019 - Present, Obligated Amount: $151121; No Anticipated Amount Set

Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women, National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development)., 9/1/2018 - 8/31/2020, Obligated Amount: $1232138; Anticipated Amount: $1232138

Assessing and Modeling Network-Level Consequences of Patient Navigation, National Institutes of Health (National Cancer Institute)., 4/1/2018 - 3/31/2021, Obligated Amount: $401459; Anticipated Amount: $406742

QUS Technology for Identifying At-Risk Women for Spontaneous Preterm Birth, National Institute of Child Health and Human Development., 9/11/2017 - 12/5/2022, Obligated Amount: $1833505; No Anticipated Amount Set

Selected Publications

Beinfeld, Molly, Wasfy, Jason H, Walton, Surrey, Sarker, Jyotirmoy, Nhan, Emily, Rind, David M, Pearson, Steven D. (2022). Mavacamten for hypertrophic cardiomyopathy: effectiveness and value.. Journal of Managed Care & Specialty Pharmacy, 28, (3), 369-375. doi:10.18553/jmcp.2022.28.3.369.

Martin, Molly A, Pugach, Oksana, Mosnaim, Giselle, Weinstein, Sally, Rosales, Genesis, Roy, Angkana, Pappalardo, Andrea A, Walton, Surrey. (2021). Community Health Worker Asthma Interventions for Children: Results From a Clinically Integrated Randomized Comparative Effectiveness Trial (2016‒2019). American Journal of Public Health, 111, (7), e1-e10. doi:10.2105/ajph.2021.306272.

Agboola, Foluso, Rind, David M, Walton, Surrey M, Herron-Smith, Serina, Quach, Danny, Pearson, Steven D. (2021). The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors.. Journal of Managed Care & Specialty Pharmacy, 27, (5), 667-673. doi:10.18553/jmcp.2021.27.5.667.

Muramatsu, Naoko, Yin, Lijuan, Berbaum, Michael L, Marquez, David X, Walton, Surrey M, Caceres, Maria, Cruz Madrid, Katya Y, Zanoni, Joseph P. (2021). Protocol for a randomized controlled trial of low-intensity physical activity for frail older adults: Promoting seniors’ health with home care aides (Pro-Home). Contemporary Clinical Trials, 104, 106362. doi:10.1016/j.cct.2021.106362.

Ariza, Juan G, Walton, Surrey M, Suarez, Adriana M, Sanabria, Mauricio, Vesga, Jasmin I. (2021). An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia. Therapeutic Apheresis and Dialysis, 25, (5), 621-627. doi:10.1111/1744-9987.13620.

Zhou, Jifang, Calip, Gregory S, Nutescu, Edith A, Han, Jin, Walton, Surrey M, Srisuwananukorn, Andrew, Galanter, William L. (2021). Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis. eJHaem, 2, (1), 94-98. doi:10.1002/jha2.161.

Jiang, Ruixuan, Shaw, James, Mühlbacher, Axel, Lee, Todd A, Walton, Surrey, Kohlmann, Thomas, Norman, Richard, Pickard, A Simon. (2020). Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off. Quality of Life Research, 30, (5), 1433-1444. doi:10.1007/s11136-020-02712-1.

Ariza, JG, Walton, SM, Sanabria, M, Vesga, J, Suarez, A, Rivera, A. (2020). PUK15 MEASURING THE ASSOCIATION OF SWITCHING PATIENTS FROM HEMODIALYSIS TO EXPANDED HEMODIALYSIS, WITH HOSPITALIZATIONS, MEDICATION USE, COSTS, AND PATIENT UTILITY. Value in Health, 23, s379-s380. doi:10.1016/j.jval.2020.04.1473.

Faulkner, Eric, Holtorf, Anke-Peggy, Walton, Surrey, Liu, Christine Y, Lin, Hwee, Biltaj, Eman, Brixner, Diana, Barr, Charles, Oberg, Jennifer, Shandhu, Gurmit, Siebert, Uwe, Snyder, Susan R, Tiwana, Simran, Watkins, John, IJzerman, Maarten J, Payne, Katherine. (2020). Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. Value in Health, 23, (5), 529-539. doi:10.1016/j.jval.2019.11.010.

Education

Degrees:
Ph.D., University of Chicago, United States, 1997
M.A., University of Chicago, United States, 1992
B.S., University of California Los Angeles, United States, 1991

Selected Presentations

Jiang, Ruixuan, Kohlmann, Thomas, Lee, Todd A, Mühlbacher, Axel, Shaw, James, Walton, Surrey, Pickard, A Simon. (2020 August 28). Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. doi:10.1007/s10198-020-01224-6.